Neumora Therapeutics, Inc. Common Stock
Neumora Therapeutics, Inc. Common Stock (NMRA) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · NMRA · as of Jun 8, 2026
Activity summary
Buy transactions
3
P-Purchase only
Sell transactions
5
12 Months
Buy/Sell ratio
0.60
Buy/Sell (by trades)
Overall sentiment
Neumora Therapeutics, Inc. Common Stock insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
NMRA insider buying and selling by quarter
NMRA insider selling · NMRA insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · NMRA ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
NMRA executive sell shares · NMRA board member insider trading · NMRA insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Feb 17, 2026 | Aurora Daljit Singh See Remarks | Sale | 6,165 | $22K | Form 4 |
| Feb 17, 2026 | Pinto Joshua President | Sale | 5,967 | $21K | Form 4 |
| Feb 17, 2026 | BERNS PAUL L See Remarks · Director | Sale | 9,819 | $34K | Form 4 |
| Feb 17, 2026 | Milligan Michael Lee See Remarks | Sale | 1,436 | $5K | Form 4 |
| Nov 11, 2025 | Aurora Daljit Singh See Remarks | Sale | 114,703 | $307K | Form 4 |
| Oct 27, 2025 | Burow Kristina Director | Purchase | 1,915,700 | $5.00M⚡ | Form 4 |
| Oct 27, 2025 | ARCH Venture Partners XII, LLC 10 percent owner | Purchase | 1,915,700 | $5.00M⚡ | Form 4 |
| Oct 27, 2025 | ARCH Venture Partners X, LLC 10 percent owner | Purchase | 1,915,700 | $5.00M⚡ | Form 4 |
| May 21, 2025 | Pinto Joshua President | Gift | 13,202 | — | Form 4 |
| May 21, 2025 | Pinto Joshua President | Gift | 13,202 | — | Form 4 |
| Feb 18, 2025 | BERNS PAUL L See Remarks · Director | Sale | 13,871 | $23K | Form 4 |
| Feb 18, 2025 | Milligan Michael Lee See Remarks | Sale | 1,978 | $3K | Form 4 |
| Feb 18, 2025 | Aurora Daljit Singh Chief Strategy Officer | Sale | 8,565 | $14K | Form 4 |
| Feb 18, 2025 | Lenz Robert A. Head of R&D | Sale | 5,614 | $9K | Form 4 |
| Feb 18, 2025 | Pinto Joshua President | Sale | 8,048 | $13K | Form 4 |
BERNS PAUL L
See Remarks · Director
Date
Feb 17
Shares
9,819
Price
$3.51
Value
$34K
Burow Kristina
Director
Date
Oct 27
Shares
1,915,700
Price
$2.61
Value
$5.00M ⚡
ARCH Venture Partners XII, LLC
10 percent owner
Date
Oct 27
Shares
1,915,700
Price
$2.61
Value
$5.00M ⚡
ARCH Venture Partners X, LLC
10 percent owner
Date
Oct 27
Shares
1,915,700
Price
$2.61
Value
$5.00M ⚡
BERNS PAUL L
See Remarks · Director
Date
Feb 18
Shares
13,871
Price
$1.69
Value
$23K
Aurora Daljit Singh
Chief Strategy Officer
Date
Feb 18
Shares
8,565
Price
$1.68
Value
$14K
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About NMRA insider trading
NMRA insider trades
Neumora Therapeutics, Inc. Common Stock (NMRA) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Aurora Daljit Singh (See Remarks), Pinto Joshua (President), BERNS PAUL L (See Remarks · Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. NMRA insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Neumora Therapeutics, Inc. Common Stock's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
NMRA insider trading · 5 questionsThe insiders of Neumora Therapeutics, Inc. Common Stock (NMRA) include executives and directors such as Aurora Daljit Singh (See Remarks), Pinto Joshua (President), BERNS PAUL L (See Remarks · Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026